Zobrazeno 1 - 10
of 478
pro vyhledávání: '"Richard E Champlin"'
Autor:
Nicholas J. Short, Sangeetha Venugopal, Wei Qiao, Tapan M. Kadia, Farhad Ravandi, Walid Macaron, Courtney D. Dinardo, Naval Daver, Marina Konopleva, Gautam Borthakur, Elizabeth J. Shpall, Uday Popat, Richard E. Champlin, Rohtesh Mehta, Gheath Al-Atrash, Betul Oran, Elias Jabbour, Guillermo Garcia-Manero, Ghayas C. Issa, Guillermo Montalban-Bravo, Musa Yilmaz, Abhishek Maiti, Hagop Kantarjian
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-10 (2022)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Treated secondary acute myeloid leukemia (ts-AML)—i.e., AML arising from a previously treated antecedent hematologic disorder—is associated with very poor outcomes. The optimal frontline treatment regimen for these patients is uncertai
Autor:
Laura K. Whited, Jose Banchs, Richard E. Champlin, Uday R. Popat, Elizabeth J. Shpall, Gabriela Rondon, Rima M. Saliba, Jason Yeh
Publikováno v:
Blood Advances
Key Points The incidence of acute cardiac toxicity remains low and manageable after matched allo-HCT in the era of PTCy prophylaxis.Older age, hypertension, arrhythmia, diabetes, and cardiac comorbidities increase this risk of cardiac toxicity but PT
Autor:
P. Andrew Futreal, Ken Furudate, Marina Konopleva, Sanam Loghavi, Guillermo Garcia-Manero, Sa A. Wang, Yuya Sasaki, Gheath Alatrash, Musa Yilmaz, Koji Sasaki, Naveen Pemmaraju, Latasha Little, Tapan M. Kadia, Koichi Takahashi, Farhad Ravandi, Kiyomi Morita, Curtis Gumbs, Jairo Matthews, Feng Wang, Hagop M. Kantarjian, Courtney D. DiNardo, Richard E. Champlin, Naval Daver, Tomoyuki Tanaka
Publikováno v:
Blood
Introduction While clonal hematopoiesis (CH) can precede the development of AML, preleukemic CH can persist after attaining remission. In rare cases, non-leukemic CH can also emerge after remission. Long-term clonal dynamics of persistent CH or emerg
Autor:
Stefan O. Ciurea, Piyanuch Kongtim, Gabriela Rondon, Salman Otoukesh, Stephen J. Forman, Richard E. Champlin, Julianne Chen, Auayporn Nademanee, Michiko Taniguchi, Kai Cao, Ketevan Gendzekhadze, Fleur M. Aung, Jun Zou, Monzr M. Al Malki
Publikováno v:
Blood Advances. 5:4031-4043
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments are needed for these patients, who often have no other donor options an
Autor:
Jun Zou, Piyanuch Kongtim, Samer A. Srour, Uri Greenbaum, Johannes Schetelig, Falk Heidenreich, Henning Baldauf, Brandt Moore, Supawee Saengboon, Yudith Carmazzi, Gabriela Rondon, Qing Ma, Katayoun Rezvani, Elizabeth J. Shpall, Richard E. Champlin, Stefan O. Ciurea, Kai Cao
Publikováno v:
Frontiers in immunology. 13
With the continuous increase in the use of haploidentical donors for transplantation, the selection of donors becomes increasingly important. Haploidentical donors have been selected primarily based on clinical characteristics, while the effects of k
Autor:
David Marin, Elias Jabbour, Denái R. Milton, Amanda Olson, Gabriela Rondon, Jin S. Im, Rohtesh S. Mehta, Uday R. Popat, May Daher, Felipe Samaniego, Loretta J. Nastoupil, Neeraj Saini, Celina Ledesma, Paolo Anderlini, Muzaffar H. Qazilbash, Qaiser Bashir, Issa F. Khouri, Alison M. Gulbis, Richard E. Champlin, L. Jeffrey Medeiros, Swaminathan P. Iyer
Publikováno v:
Clinical Cancer Research. 27:5847-5856
Purpose: To compare outcomes between patients with relapsed follicular lymphoma who received a nonmyeloablative allogeneic stem cell transplant (alloSCT) and those who received an autologous transplant (autoSCT). Patients and Methods: We evaluated 19
Autor:
Richard E. Champlin, Amanda Olson, Uri Greenbaum, Gheath Alatrash, Rohtesh S. Mehta, Rima M. Saliba, Katayoun Rezvani, Jeremy Ramdial, Jacinth Joseph, Muzaffar H. Qazilbash, Amin M. Alousi, Fevzi Firat Yalniz, David Marin, Jin Im, Betul Oran, Elizabeth J. Shpall, Partow Kebriaei, Gabriela Rondon, Uday R. Popat, Rashmi Kanagal-Shamanna, Chitra Hosing
Publikováno v:
Transplantation and Cellular Therapy. 27:689-695
Relapse after allogeneic hematopoietic cell transplantation (HCT) leads to poor survival in patients with acute myeloid leukemia (AML). A second HCT (HCT2) may achieve durable remission. To determine the outcomes of patients who received an HCT2 for
Autor:
Aimaz Afrough, Oren Pasvolsky, Junsheng Ma, Samer Srour, Qaiser Bashir, Neeraj Saini, Chitra Hosing, Uday R. Popat, Partow Kebriaei, Ruby Delgado, Muhammad R. Ullah, Regan Murphy, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Krina K. Patel, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash
Publikováno v:
Transplantation and cellular therapy. 28(6)
Induction therapy with a triplet regimen, followed by high-dose therapy and autologous hematopoietic stem cell transplantation (auto-HCT), is the standard of care for newly diagnosed, transplant-eligible patients with multiple myeloma (MM). Bortezomi
Autor:
Celina Ledesma, Gabriela Rondon, Ankur Varma, Rima M. Saliba, Stefan O. Ciurea, Richard E. Champlin, Julianne Chen, Samer A. Srour
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1013-1020
Fluid overload (FO) grade ≥2 (more than 10% weight gain from baseline) has recently been recognized as an important toxicity associated with a high rate of nonrelapse mortality in recipients of allogeneic hematopoietic cell transplantation (AHCT).
Autor:
Helen Huls, G. Bardelli, J. Buck, E. de Groot, Partow Kebriaei, Amin M. Alousi, Samer A. Srour, Chitra Hosing, David Marin, William G. Wierda, Harjeet Singh, Y. Nieto, Hagop M. Kantarjian, Jessica McCarty, Laurence J.N. Cooper, U. Popat, Elizabeth J. Shpall, Richard E. Champlin, Stefan O. Ciurea, Gabriella Rondon, Katy Rezvani, M.H. Qazilbash
Publikováno v:
Blood